Stem cell policies in the United States and in Germany: Between bioethics and regulation

The article compares policymaking in the field of human embryonic stem cell research in the United States and in Germany. Although experimental research with human stem cells is controversial in both countries, restrictions on research are much more strict in Germany than in the United States. In order to explain the contrast between the United States and Germany in dealing with human embryonic stem cell research and to predict possible future developments, we need to look carefully at a number of important differences in the interpretations and discourses of embryonic stem cell research and their consequences for the strategies of institutions and actors in the political-regulatory realm.